Bleakley Financial Group LLC Sells 664 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Bleakley Financial Group LLC cut its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 9.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,367 shares of the company’s stock after selling 664 shares during the period. Bleakley […]
![Bleakley Financial Group LLC Sells 664 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/protagonist-therapeutics-inc-logo-1200x675.png?v=20240509145620&w=240&h=240&zc=2)